Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines
-
Published:2023-03-11
Issue:12
Volume:65
Page:1979-1990
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Ranapour SanazORCID, Motamed NasrinORCID
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference74 articles.
1. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65(2), 87–108. 2. Fouladi, N., Barahman, M., Amani, F., Bahadoram, M., & Eghbali, S. (2019). Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran. Immunopathologia Persa, 6(1), e02. 3. Zhao, D., Zeng, S., Zhou, H., Cai, X., Wang, Z., & Zhang, H. (Eds.). (2022). Research on image guided path planning for gynecologic tumor thermal ablation. MRE Press. 4. Liu, J., Zhang, L., Ren, Y., Gao, Y., Kang, L., & Qiao, Q. (2014). Anticancer and immunoregulatory activity of Gynostemma pentaphyllum polysaccharides in H22 tumor-bearing mice. International journal of biological macromolecules, 69, 1–4. 5. Darwish, M. M., Riad, A. Y., Salem, D. A., Essa, A. E., Shakweer, M. M., & Sherif, D. E. M. (2021). Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer. Immunopathologia Persa, 8(1), e18.
|
|